Sandoz Group AG (SDZXF)

Market Cap	17.36B
Revenue (ttm)	10.38B
Net Income (ttm)	n/a
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.73 (1.87%)
Ex-Dividend Date	Apr 17, 2025

Volume	176
Average Volume	1,870
Open	39.37
Previous Close	n/a
Day's Range	39.37 - 39.37
52-Week Range	25.75 - 44.15
Beta	n/a
RSI	42.86
Earnings Date	Aug 7, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 22,049
• Stock Exchange: OTCMKTS
• Ticker Symbol: SDZXF